Sort by
Refine Your Search
-
the field of dermatology, leveraging epidemiology, data science, and public health to advance health equity. Leandra A. Barnes, MD is an NIH-funded K scholar committed to elucidating the underlying mechanisms
-
. Qualifications for this position include a PhD in Computer Science, Artificial Intelligence, Natural Language Processing, Human-Computer Interaction, or a closely related field. Candidates should have demonstrated
-
in relevant fields. Required Application Materials: A cover letter outlining research interests and relevant experience. A current CV. Contact information for three references. Stanford is an equal
-
Application Materials: Cover letter CV Contact information for three references Stanford is an equal opportunity employer and all qualified applicants will receive consideration without regard to race, color
-
/summerhanlab.html (link is external) How to Submit Application Materials: Please email a cover letter, CV, a short description of research interests, and contact information of three referees to: Summer Han, Ph.D
-
the appointment, but not more than 2 years before. Required Application Materials: Cover letter (one page) Curriculum vitae, including a list of publications Brief statements of proposed research (up to three pages
-
Application Materials: Please send your application package as a zipped file to kseetah@stanford.edu (link sends e-mail) , with the subject line: Application for 'Integrating Natural and Cultural Data' postdoc
-
, surrounded by Stanford’s hubs for medicine, computer science, and data science —perfect for interdisciplinary science. Required Qualifications: Ph.D. in Molecular Biology, Cell Biology, Developmental Biology
-
. Required Application Materials: Cover letter (2 pages) CV Copies of two research papers that demonstrate research agenda Contact information for two references Stanford is an equal opportunity employer and
-
research on multimodal data from patients receiving engineered T cell immunotherapies. We have recently completed groundbreaking clinical studies of CD19/CD22-targeted and GD2-targeted CAR T cell therapies